Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8731 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD3027 |
Phase 3 |
0.8657 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8613 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8613 |
High Similarity |
NPD1613 |
Approved |
0.8394 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8258 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8201 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8058 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7949 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7923 |
Intermediate Similarity |
NPD228 |
Approved |
0.7888 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD37 |
Approved |
0.7857 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7707 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7707 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7698 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7698 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7698 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7698 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7481 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7294 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7294 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7248 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7219 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7183 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7154 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7153 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7124 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7115 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7103 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD846 |
Approved |
0.7099 |
Intermediate Similarity |
NPD940 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD1669 |
Approved |
0.707 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD2532 |
Approved |
0.707 |
Intermediate Similarity |
NPD2534 |
Approved |
0.707 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7067 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7055 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD709 |
Approved |
0.7042 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7032 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7012 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD943 |
Approved |
0.7 |
Intermediate Similarity |
NPD7472 |
Approved |
0.6994 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD2935 |
Discontinued |
0.698 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.698 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.698 |
Remote Similarity |
NPD5109 |
Approved |
0.698 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6977 |
Remote Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4538 |
Approved |
0.6974 |
Remote Similarity |
NPD4536 |
Approved |
0.6974 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7906 |
Approved |
0.6968 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4675 |
Approved |
0.6957 |
Remote Similarity |
NPD4678 |
Approved |
0.6954 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6951 |
Remote Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD5762 |
Approved |
0.6948 |
Remote Similarity |
NPD5763 |
Approved |
0.6948 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6948 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD1091 |
Approved |
0.6944 |
Remote Similarity |
NPD3092 |
Approved |
0.6939 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD4577 |
Approved |
0.6936 |
Remote Similarity |
NPD4578 |
Approved |
0.6933 |
Remote Similarity |
NPD5929 |
Approved |
0.6929 |
Remote Similarity |
NPD6671 |
Approved |
0.6928 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD5126 |
Approved |
0.6923 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD4663 |
Approved |
0.6914 |
Remote Similarity |
NPD5090 |
Approved |
0.6914 |
Remote Similarity |
NPD5089 |
Approved |
0.6913 |
Remote Similarity |
NPD7095 |
Approved |
0.6909 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6906 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD3226 |
Approved |
0.6894 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD5405 |
Approved |
0.6883 |
Remote Similarity |
NPD2438 |
Suspended |
0.6883 |
Remote Similarity |
NPD5408 |
Approved |
0.6883 |
Remote Similarity |
NPD5404 |
Approved |
0.6883 |
Remote Similarity |
NPD5406 |
Approved |
0.6882 |
Remote Similarity |
NPD8252 |
Approved |
0.6882 |
Remote Similarity |
NPD8251 |
Approved |
0.6882 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6879 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7340 |
Approved |
0.6879 |
Remote Similarity |
NPD2677 |
Approved |
0.6879 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6867 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD2489 |
Approved |
0.6864 |
Remote Similarity |
NPD27 |
Approved |
0.6863 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6861 |
Remote Similarity |
NPD5451 |
Approved |
0.686
|
Remote Similarity |
NPD6797 |
Phase 2 |